UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form  i 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  i September 16, 2020

 

 i INNOSPEC INC.

(Exact name of registrant as specified in its charter)

 

Commission File Number:  i 1-13879

 

i Delaware		i 98-0181725
(State or other jurisdiction of incorporation)		(IRS Employer Identification No.)

 i 8310 South Valley Highway

 i Suite 350

 i Englewood,  i Colorado,  i 80112

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code):  i (303) i 792-5554

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
i Common Stock, par value $0.01 per share		i IOSP		i NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company   i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 1.01

Entry into a Material Definitive Agreement.

As disclosed in its Form 8-K filed September 30, 2019, Innospec Inc. (the “Company”) and certain subsidiaries of the Company (together with the Company, the “Borrowers”) entered into a Multicurrency Revolving Facility Agreement with various lenders (the “Agreement”) providing for a $250,000,000 multicurrency revolving loan facility available to the Borrowers (the “Facility”). The Agreement initially provided that the termination date of the Facility was September 25, 2023, but gave the Company an option to request an extension of the Facility for a further year. In accordance with the terms of the Agreement, the Company requested that the Facility be extended to September 26, 2024. On September 16, 2020, the agent for the Agreement notified the Company that all of the lenders agreed to the extension and confirmed that “the Termination Date is now extended to 26 September 2024.” No other terms of the Agreement or the Facility were modified. The Company paid a customary extension fee in connection with the extension of the Facility as contemplated by the Agreement.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

See Item 1.01 above, which is incorporated herein by reference.

 

Item 9.01.

Financial Statements and Exhibits.

 

(d)

Exhibits.

EXHIBIT INDEX

 

Number		Description		Method of Filing
10.1		Extension Request for Multicurrency Revolving Facility Agreement and Confirmation			Filed Herewith
104		Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: October 6, 2020

 

3